Filing Flows › Cocrystal Pharma (COCP) › Q2 2026 › vs Q1 2026
Cocrystal Pharma (COCP) Q2 2026 vs Q1 2026 (quarter over quarter)
Cocrystal Pharma's revenue fell $120K (-53%) from $225K in Q1 2026 to $105K in Q2 2026.
Cocrystal Pharma, Q2 2026: revenue $105K, net loss $3.2M, operating cash flow −$2.5M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $105K | $225K | −$120K | -53% |
| Other income, net | $20K | $57K | −$37K | -65% |
| Net loss | $3.2M | $2.3M | $865K | +38% |
| Costs & expenses | $3.3M | $2.6M | $708K | +27% |
| Operating costs | $3.3M | $2.6M | $708K | +27% |
| Research & development | $2.1M | $1.4M | $771K | +56% |
| General & admin | $1.1M | $1.2M | −$63K | -5% |
| Operating cash sources | $3.2M | $2.3M | $865K | +38% |
| Depreciation & amortization | $12K | $12K | $0 | 0% |
| Share-based compensation | $92K | $84K | $8K | +10% |
| Working capital & other | $544K | −$137K | $681K | — |
| Cash used in operations | $2.5M | $2.3M | $176K | +8% |
| Net loss absorbed | $3.2M | $2.3M | $865K | +38% |
Questions
How much did Cocrystal Pharma's revenue grow quarter over quarter in Q2 2026?
Cocrystal Pharma's revenue fell $120K (-53%) from $225K in Q1 2026 to $105K in Q2 2026.